Diagnostic validity contingency table and parameter estimates of PS29MRC
| PS29MRCdic . | Induction failure . | Induction response . | Total . | Measure (95% CI) . |
|---|---|---|---|---|
| High | 60 | 57 | 117 | PPV: 0.51 (95% CI, 0.42-0.61) |
| Low | 42 | 192 | 234 | NPV: 0.82 (95% CI, 0.77-0.87) |
| Total | 102 | 249 | 351 | |
| SEN: 0.59 (95% CI, 0.49-0.68) | SPE: 0.77 (95% CI, 0.71-0.82) | DOR: 4.81 (95% CI, 2.94-7.88) |
| PS29MRCdic . | Induction failure . | Induction response . | Total . | Measure (95% CI) . |
|---|---|---|---|---|
| High | 60 | 57 | 117 | PPV: 0.51 (95% CI, 0.42-0.61) |
| Low | 42 | 192 | 234 | NPV: 0.82 (95% CI, 0.77-0.87) |
| Total | 102 | 249 | 351 | |
| SEN: 0.59 (95% CI, 0.49-0.68) | SPE: 0.77 (95% CI, 0.71-0.82) | DOR: 4.81 (95% CI, 2.94-7.88) |
| . | Point estimates . | 95% CI . | ||
|---|---|---|---|---|
| Apparent prevalence | 0.33 | 0.28-0.39 | ||
| True prevalence | 0.29 | 0.24-0.34 | ||
| Positive likelihood ratio | 2.57 | 1.94-3.40 | ||
| Negative likelihood ratio | 0.53 | 0.42-0.68 | ||
| . | Point estimates . | 95% CI . | ||
|---|---|---|---|---|
| Apparent prevalence | 0.33 | 0.28-0.39 | ||
| True prevalence | 0.29 | 0.24-0.34 | ||
| Positive likelihood ratio | 2.57 | 1.94-3.40 | ||
| Negative likelihood ratio | 0.53 | 0.42-0.68 | ||
CI, confidence interval; DOR, diagnostic OR; NPV, negative predictive value; PPV, positive predictive value; SEN, sensitivity; SPE, specificity.